Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2026-03-04 @ 9:36 PM
Study NCT ID:
NCT02028494
Status:
UNKNOWN
Last Update Posted:
2018-09-07
First Post:
2014-01-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Response to Two Schedules of Capecitabine in Patients With Metastatic Breast Cancer
Sponsor:
Latin American & Caribbean Society of Medical Oncology
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SLACOM Cap 7/7
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |